Identification of Increased Genetic Risk Scores for Schizophrenia in Treatment-Resistant Patients

Molecular Psychiatry - United Kingdom
doi 10.1038/mp.2015.52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Evidence for Genetic Contribution to the Increased Risk of Type 2 Diabetes in Schizophrenia

Translational Psychiatry
PsychiatryMolecular NeuroscienceBiological PsychiatryMental HealthCellular
2018English

Polygenic Risk Scores in Clinical Schizophrenia Research

American Journal of Psychiatry
PsychiatryMental Health
2019English

Genetic Risk Factors for Schizophrenia

International Journal of Mental Health
Mental HealthEnvironmentalPublic HealthHealth PolicyPsychiatryOccupational Health
2000English

Clozapine in Treatment-Resistant Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
2017English

Consanguinity and Increased Risk for Schizophrenia in Egypt

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2010English

Higher Polygenic Risk Scores for Schizophrenia May Be Suggestive of Treatment Non-Response in Major Depressive Disorder

2020English

Randomized Controlled Trial of Occupational Therapy in Patients With Treatment-Resistant Schizophrenia

Revista Brasileira de Psiquiatria
PsychiatryMental Health
2003English

Increased Metabolic and Cardiovascular Morbidity in Patients With Schizophrenia: Recommendation for Diagnoses and Treatment

Annals of General Psychiatry
PsychiatryMental Health
2010English

Use of Sex-Specific Clinical and Exercise Risk Scores to Identify Patients at Increased Risk for All-Cause Mortality

JAMA Cardiology
Cardiovascular MedicineCardiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy